Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

PANTOPRAZOLE SODIUM

PANTOPRAZOLE SODIUM

Standard Dose
EQ 40MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PANTOPRAZOLE SODIUM is listed in Drugs@FDA under application 217923 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PANTOPRAZOLE SODIUM Form and strength FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2025-03-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview PANTOPRAZOLE SODIUM is listed in Drugs@FDA under application 217923 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PANTOPRAZOLE SODIUM Form and strength FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2025-03-31 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.